跳转至内容
Merck
CN
HomeWebinarsHow deuterated tracers allow us imaging metabolism in vivo

How deuterated tracers allow us imaging metabolism in vivo



WEBINAR

Magnetic resonance has truly transformed the landscape of medical diagnostics and chemical analysis. The minute magnetic moments of nuclear spins have proven invaluable for elucidating molecular structures, identifying chemical compounds, and imaging anatomical features and physiological functions in vivo. Despite these advancements, there remains a significant, unmet need in the medical field for techniques that can effectively measure—and ideally image—the biochemistry and metabolism that underpin anatomical structures.

In this context, in vivo magnetic resonance spectroscopy emerges as a promising solution, offering unique insights into metabolic processes. However, its potential is often limited by the signal-to-noise ratio achievable within practical time frames. Consequently, in vivo measurements typically detect only large metabolite pools at millimolar concentrations, leaving a wealth of biochemical information unexamined.

Recently, two innovative yet established approaches have gained prominence in addressing these challenges: hyperpolarized magnetic resonance, which enhances the alignment of nuclear spins in tracers, and deuterium magnetic resonance, which utilizes deuterated molecules to trace metabolic pathways. The latter, which is the focal point of this presentation, leverages the rapid recovery of deuterium from excitation compared to hydrogen, allowing for a greater number of averages to be acquired and significantly enhancing the signal. Additionally, deuterium's low background signal—thanks to its natural abundance of only 0.015%—minimizes interference from unwanted signals, a common issue in hydrogen magnetic resonance. The ease of deuterating molecules, such as glucose, further simplifies the application of this technique. In this presentation, I will delve into these advancements and discuss recent developments that promise to enhance our understanding of metabolic processes through innovative magnetic resonance techniques.

Speaker

Jan-Bernd Hövener

Jan-Bernd Hövener

University of Kiel, Germany

Professor

Prof. Jan-Bernd Hövener studied physics at the universities of Münster, Nice, and Heidelberg. After completing his diploma thesis at the German Cancer Research Center in Heidelberg in the field of medical physics and spending time at New York University, he conducted research at the Huntington Medical Research Institute and the California Institute of Technology in Pasadena, USA. He received his doctorate in 2008 from the Faculty of Astronomy and Physics in Heidelberg on the topic of hyperpolarized magnetic resonance imaging. Subsequently, Hövener joined the research group of Jürgen Klaus Hennig at the University Hospital Freiburg. In Freiburg, he was accepted into the 4th Excellence Academy for Young Researchers in Medical Technology of the DFG; he was a member of the German Consortium for Translational Cancer Research and deputy head of the MasterOnline program in "Technical Medicine." From 2014 to 2022, he led the Emmy Noether Group for Metabolic and Molecular MRI. Hövener habilitated in 2016 at the University of Freiburg in the field of "Experimental Radiology." Since June 2017, he has been a professor of Translational Magnetic Resonance Imaging at the Medical Faculty of Christian-Albrechts-University in Kiel, as well as the head of the Section for Biomedical Imaging in the Department of Radiology and Neuroradiology at the University Hospital Schleswig-Holstein (UKSH), Kiel Campus, and the head of the Molecular Imaging North Competence Center (MOIN CC), the state competence center for preclinical imaging and core facility of Kiel University.

Webinar Information

Pharmacology and drug discovery research

  • IVD manufacturing
  • 期间:1h

  • 语言:English

  • 场次 1:Wed, December 17, 2025 9:00 AM CEST

    Register Now

  • 场次 2:Wed, December 17, 2025 6:00 PM CEST

    Register Now


登录以继续。

如要继续阅读,请登录或创建帐户。

暂无帐户?